Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patients-Reference-Cited by-同舟云学术

Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patients

Published:2015-10-23 Issue:16 Volume:29 Page:2099-2108
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Duffau Pierre,Wittkop Linda,Lazaro Estibaliz,le Marec Fabien,Cognet Céline,Blanco Patrick,Moreau Jean-François,Dauchy Frédéric-Antoine,Cazanave Charles,Vandenhende Marie-Anne,Bonnet Fabrice,Thiebaut Rodolphe,Pellegrin Isabelle

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference26 articles.

1. The end of AIDS: HIV infection as a chronic disease.;Deeks;Lancet,2013

2. Premature age-related comorbidities among HIV-infected persons compared with the general population.;Guaraldi;Clin Infect Dis,2011

3. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation.;Armah;Clin Infect Dis,2012

4. Systemic effects of inflammation on health during chronic HIV infection.;Deeks;Immunity,2013

5. Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384.;Gandhi;J Acquir Immune Defic Syndr,2006

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term effects on immunological, inflammatory markers, and HIV-1 reservoir after switching to a two-drug versus maintaining a three-drug regimen based on integrase inhibitors;Frontiers in Immunology;2024-07-11

2. Chronic immune activation and accelerated immune aging among HIV-infected adults receiving suppressive antiretroviral therapy for at least 12 years in an African cohort;Heliyon;2024-06

3. Impact of HIV-Related Immune Impairment of Yellow Fever Vaccine Immunogenicity in People Living with HIV—ANRS 12403;Vaccines;2024-05-25

4. HIV-1-specific T-cell responses and exhaustion profiles in people with HIV after switching to dual therapy vs. maintaining triple therapy based on integrase inhibitors;Biomedicine & Pharmacotherapy;2023-12

5. Immune recovery among Romanian HIV/AIDS patients receiving darunavir/ritonavir or darunavir/cobicistat regimens in cART management: A three-year study;Biomedicine & Pharmacotherapy;2023-05